$SWAV News
Last published 7mo ago
- 7mo agoISRGGDTSWAVPRCTSonder Capital Closes its Second Fund and Announces Participation from Major Healthcare SystemsPR NewswireSonder Capital, a healthcare venture capital firm investing in companies revolutionizing the standard of care, today announced the closing of its...
- 11mo agoSWAVCSIIShockwave Medical, Inc. vs Cardiovascular Systems, Inc. - AIA Trial, Affirmed/Reversed in PartUS Patent Trial and Appeal Board
- 1y agoBRKRPGNYSIBNSWAVBruker Appoints Laura Francis to its Board of DirectorsBusiness WireBruker Corporation (NASDAQ:BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected
- 2y agoSNBRISRGSWAVPRCTDeborah Kilpatrick Joins Sonder Capital as its Newest Venture PartnerPR NewswireSonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced the...
- 2y agoSWAVShockwave Medical, Inc. - Appeal, ReversedUS Patent Trial and Appeal Board
- 2y agoSWAVALEPRFTLSAKKuehn Law Encourages SWAV, ALE, PRFT, and LSAK Investors to Contact Law FirmPR NewswireKuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may...
- 2y agoJNJSWAVShockwave Medical Reports First Quarter 2024 Financial ResultsGlobeNewswireSANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 2y agoIPNXSWAVUNITKuehn Law Encourages IP, SWAV, NX, and UNIT Investors to Contact Law FirmGlobeNewswireNEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 2y agoABIOMODNSWAVWIREKuehn Law Encourages WIRE, ABIO, MODN, and SWAV Investors to Contact Law FirmGlobeNewswireNEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 2y agoJNJHUMUNHundefined+2Johnson & Johnson tops quarterly profit estimates as medical device sales jumpCNBCThe company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic.
- 2y agoSWAVSWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical to Johnson & JohnsonGlobeNewswireMONSEY, N.Y., April 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $335.00 per share in cash for which Shockwave Medical, Inc. (NASDAQ:SWAV)
- 2y agoSWAVShockwave Reducer Demonstrates Consistent, Positive Results in 'Real-World' StudyGlobeNewswireSANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 2y agoKTRAABIOSWAVNSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law FirmPR NewswireKuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may...
- 2y agoJNJSWAVJohnson & Johnson to Acquire Shockwave MedicalBusiness WireEnhances Johnson & Johnson's Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech's Position in Highest-Growth,
- 2y agoISRGPRCTSWAVSonder Capital Appoints Kate Garrett as Managing Partner to Lead Next Generation of GrowthBusiness WireCo-founders and industry luminaries Dr. Fred Moll and Jay Watkins will assume the newly created role of Co-chair as firm closes its latest fund, Futures II Sonder Capital, a leading venture capital firm focused on
- 2y agoSWAVShockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewswireSANTA CLARA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 2y agoSWAVProtembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of DirectorsBusiness WireFinancing and Reinforcement of Board of Directors Builds Momentum in Readiness for the Initiation of the IDE Pivotal Trial Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company,
- 2y agoSWAVShockwave Medical, Inc. (SWAV) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoSWAVShockwave Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswireSANTA CLARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 2y agoSWAVShockwave Medical Appoints Renee Gaeta as Chief Financial OfficerGlobeNewswireSANTA CLARA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 2y agoSWAVShockwave Medical Provides Quarterly Earnings Release Dates for 2024GlobeNewswireSANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- January 8, 2024 – Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of
- 2y agoSWAVShockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewswireSANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular
- 2y agoPRCTSWAVNeptune Medical Appoints Dr. Fred Moll as Chairman of the BoardBusiness WireNeptune Medical, a leading innovator in medical technology, is pleased to announce the appointment of Dr. Fred Moll as Chairman of the Board. Dr. Moll, a seasoned entrepreneur and influential figure in the medical
- 2y agoSWAVShockwave Medical to Participate in the Piper Sandler 35th Annual Healthcare ConferenceGlobeNewswireSANTA CLARA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular
- 3y agoSWAVNew Shockwave Coronary IVL Publication Shows Similar Outcomes in Women And MenGlobeNewswireSANTA CLARA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVShockwave Medical Reports Third Quarter 2023 Financial ResultsGlobeNewswireSANTA CLARA, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVCenters for Medicare & Medicaid Services Establishes New Category I CPT® Add-On Code for Coronary IVLGlobeNewswireSANTA CLARA, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVShockwave Medical Announces Details for Conference Call Discussing Third Quarter 2023 Results and Participation in Upcoming Investor ConferenceGlobeNewswireSANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular
- 3y agoSWAVShockwave Medical Introduces Enhanced Coronary IVL Catheter in the United StatesGlobeNewswireShockwave C2+ Debut Joins Packed Shockwave Agenda at Transcatheter Cardiovascular Therapeutics Conference in San Francisco SANTA CLARA, Calif., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc.
- 3y agoSWAVNew Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium MorphologiesGlobeNewswireSANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVShockwave Medical to Livestream 2023 Investor Innovation DayGlobeNewswireSANTA CLARA, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVShockwave Medical Appoints Nick West as Associate Chief Medical OfficerGlobeNewswireSANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVShockwave Medical Announces Dan Puckett to Retire as CFO in 2024GlobeNewswireSANTA CLARA, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVShockwave Medical to Participate in Upcoming Investor ConferencesGlobeNewswireSANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular
- 3y agoSWAVShockwave Medical Prices Upsized Private Offering of $650.0 Million of 1.00% Convertible Senior Notes Due 2028GlobeNewswireSANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV) ("Shockwave Medical") announced today the pricing of its offering of $650.0 million aggregate principal amount of 1.00%
- 3y agoSWAVShockwave Medical Announces Proposed Private Offering of $500.0 Million of Convertible Senior NotesGlobeNewswireSANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV) ("Shockwave Medical") announced today that it intends to offer, subject to market conditions and other factors, $500.0
- 3y agoSWAVShockwave Medical Reports Second Quarter 2023 Financial ResultsGlobeNewswireSANTA CLARA, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVShockwave Medical Announces Details for Conference Call Discussing Second Quarter 2023 Results and Participation in Upcoming Investor ConferenceGlobeNewswireSANTA CLARA, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular
- 3y agoCVNALCIDSWAVDKNG+4Stocks making the biggest moves midday: Carvana, Icahn Enterprises, Novavax, Fisker and moreCNBCThese are the stocks posting the largest moves in midday trading.
- 3y agoAAPIEPMETAFSR+3Stocks making the biggest premarket moves: Advance Auto Parts, Icahn Enterprises, Meta, Fisker and moreCNBCThese are the stocks posting the largest moves in the premarket.
- 3y agoSWAVShockwave Medical Publishes 2022 ESG ReportGlobeNewswireSANTA CLARA, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVIntravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR - NCT05862558ClinicalTrials.govAcute technical success per the DISRUPT PAD definition at the time of intervention, Success rate of transfemoral delivery of a TAVR system post IVL within 30 days of treatment, Applicable VARC-3 criteria at the time of peripheral intervention for bleeding, access site and access related complications., Major adverse events within 1 year
- 3y agoSWAVShockwave Appoints Kevin Ballinger to Board of DirectorsGlobeNewswireSANTA CLARA, Calif., May 17, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
- 3y agoSWAVShockwave Medical Launches New Coronary IVL Catheter Internationally and Enrolls First Patient in All-Female Empower StudyGlobeNewswireShockwave C2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries SANTA CLARA, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and
- 3y agoSWAVShockwave Medical Reports First Quarter 2023 Financial ResultsGlobeNewswireSANTA CLARA, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified
- 3y agoSWAVShockwave Medical Announces Details for Conference Call Discussing First Quarter 2023 Results and Participation in Upcoming Investor ConferenceGlobeNewswireSANTA CLARA, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, will
- 3y agoSWAVShockwave Medical Completes Acquisition of NeovascGlobeNewswireSANTA CLARA, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV) ("Shockwave"), a pioneer in the development of Intravascular Lithotripsy ("IVL") to treat severely calcified cardiovascular
- 3y agoSWAVShockwave Medical Announces U.S. Launch of New Peripheral IVL CatheterGlobeNewswireSANTA CLARA, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today
- 3y agoSWAVEquity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease - NCT05755711ClinicalTrials.govPrimary Safety Endpoint, Primary Effectiveness Endpoint
- 3y agoSWAVShockwave Medical Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewswireSANTA CLARA, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified